HRS cells secrete the chemokines CCL17 (also known as thymus and activation-regulated chemokine, TARC) and CCL22, which recruit CCR4-expressing Th2 cells and Tregs, promoting an immunosuppressive milieu that facilitates tumor survival. The gene discussed is CCL22; the disease is neoplasm.